ROBERT BAUMGARTNER V. - 10 May 2022 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Director
Signature
/s/ Brenda S. Furlow as Attorney-in-Fact for Robert V. Baumgartner pursuant to Power of Attorney previously filed.
Issuer symbol
TECH
Transactions as of
10 May 2022
Net transactions value
+$105,765
Form type
4
Filing time
11 May 2022, 16:52:15 UTC
Previous filing
01 Nov 2021
Next filing
31 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Purchase $105,765 +300 +3.1% $352.55 10,106 10 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TECH Stock Options (Right to Buy) 1,507 10 May 2022 Common Stock 1,507 $255.69 Direct
holding TECH Stock Options (Right to Buy) 633 10 May 2022 Common Stock 633 $515.24 Direct F1
holding TECH Stock Options (Right to Buy) 3,985 10 May 2022 Common Stock 3,985 $101.19 Direct
holding TECH Stock Options (Right to Buy) 3,125 10 May 2022 Common Stock 3,125 $125.05 Direct
holding TECH Stock Options (Right to Buy) 1,898 10 May 2022 Common Stock 1,898 $179.84 Direct
holding TECH Stock Options (Right to Buy) 2,011 10 May 2022 Common Stock 2,011 $201.64 Direct
holding TECH Stock Options (Right to Buy) 4,000 10 May 2022 Common Stock 4,000 $91.78 Direct
holding TECH Stock Options (Right to Buy) 4,260 10 May 2022 Common Stock 4,260 $87.34 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of the one year anniversary of the grant date (10/28/21) or the date of Bio-Techne's 2022 annual meeting of shareholders.